Roche's Molecular Dx, Applied Science Revenues Rise in First-Half '09 | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales rose 5 percent and its applied science revenues increased 8 percent year over year for the first half of 2009.

The Swiss pharmaceuticals, diagnostics, and life sciences firm reported molecular diagnostic sales of CHF594 million (US$553.8 million), up 5 percent, while its applied science business brought in revenues of CHF 403 million, an increase of 8 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.